Cargando…
Myelopoietic Efficacy of Orlistat in Murine Hosts Bearing T Cell Lymphoma: Implication in Macrophage Differentiation and Activation
Orlistat, an inhibitor of fatty acid synthase (FASN), acts as an antitumor agent by blocking de novo fatty acid synthesis of tumor cells. Although, myelopoiesis also depends on de novo fatty acid synthesis, the effect of orlistat on differentiation of macrophages, which play a central role in host’s...
Autores principales: | Kant, Shiva, Kumar, Ajay, Singh, Sukh Mahendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857782/ https://www.ncbi.nlm.nih.gov/pubmed/24349275 http://dx.doi.org/10.1371/journal.pone.0082396 |
Ejemplares similares
-
Correction: Myelopoietic Efficacy of Orlistat in Murine Hosts Bearing T Cell Lymphoma: Implication in Macrophage Differentiation and Activation
Publicado: (2014) -
Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells
Publicado: (1989) -
Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1
por: Broxmeyer, Hal E., et al.
Publicado: (1999) -
Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011) -
Remodeling of nuclear landscapes during human myelopoietic cell differentiation maintains co-aligned active and inactive nuclear compartments
por: Hübner, Barbara, et al.
Publicado: (2015)